Legend Biotech Corporation
LEGN
$35.36
-$0.27-0.76%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.24% | -483.94% | 120.97% | -588.73% | 69.57% |
| Total Depreciation and Amortization | 12.60% | -21.11% | 27.76% | -3.93% | -6.17% |
| Total Amortization of Deferred Charges | -- | -- | -34.39% | -- | -- |
| Total Other Non-Cash Items | 116.74% | 286.85% | -157.12% | 658.56% | 133.11% |
| Change in Net Operating Assets | 51.63% | 8.10% | -360.37% | -664.92% | -96.73% |
| Cash from Operations | 87.43% | -26.41% | -8.25% | -4,492.49% | -110.64% |
| Capital Expenditure | -360.74% | 15.81% | -15.16% | 39.57% | 45.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -160.43% | 402.63% | -125.81% | 147.84% | -77.53% |
| Cash from Investing | -164.50% | 392.16% | -126.69% | 147.31% | -75.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -62.55% | 16.99% | 19.59% | -0.34% | -53.03% |
| Issuance of Common Stock | -81.09% | 139.47% | -88.85% | 155.74% | 33.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -248.43% | 300.30% | -107.84% | 344.50% | 14.92% |
| Foreign Exchange rate Adjustments | 217.21% | 161.54% | -534.16% | 5,722.22% | 102.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -213.01% | 189.81% | -166.87% | 137.06% | -83.17% |